Stockscreener 앱 받기
1.9899
1.18%
-0.0101
전일 마감가:
$2.00
열려 있는:
$2
하루 거래량:
4,114
Relative Volume:
0.03
시가총액:
$55.99M
수익:
$48.20M
순이익/손실:
$-35.05M
주가수익비율:
-1.2696
EPS:
-1.5673
순현금흐름:
$-13.02M
1주 성능:
+2.67%
1개월 성능:
+1.36%
6개월 성능:
-6.33%
1년 성능:
-3.11%
1일 변동 폭
$1.9765
$2.00
1주일 범위
$1.94
$2.29
52주 변동 폭
$1.06
$4.35
Celularity Inc Stock (CELU) Company Profile
명칭
Celularity Inc
전화
(908) 768-2170
주소
170 PARK AVE, FLORHAM PARK
CELU을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CELU
Celularity Inc
|
1.9765 | 56.66M | 48.20M | -35.05M | -13.02M | -1.5673 |
|
VRTX
Vertex Pharmaceuticals Inc
|
430.93 | 110.02B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
778.45 | 82.00B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
451.18 | 59.61B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
893.24 | 56.15B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
206.44 | 44.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Celularity Inc Stock (CELU) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-01-30 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2022-12-22 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2022-06-22 | 개시 | H.C. Wainwright | Buy |
| 2022-04-06 | 다운그레이드 | Truist | Buy → Hold |
| 2022-01-28 | 개시 | Oppenheimer | Outperform |
| 2021-11-24 | 개시 | Morgan Stanley | Equal-Weight |
모두보기
Celularity Inc 주식(CELU)의 최신 뉴스
Celularity Inc. (CELU) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Celularity, Inc. Forms Death Cross, Signaling Potential Bearish Trend Ahead - Markets Mojo
[Form 4] Celularity Inc Insider Trading Activity - Stock Titan
Form 4: Celularity (CELU) director now holds 248,765 Class A shares - Stock Titan
Is Celularity Inc. Equity Warrant stock attractive after correctionWeekly Trading Summary & Expert Verified Movement Alerts - newser.com
Will Celularity Inc. Equity Warrant stock attract more institutional investors - newser.com
Is Celularity Inc a good long term investmentLarge Cap Stability Picks & Accelerated Capital Growth - earlytimes.in
Chart based analysis of Celularity Inc. Equity Warrant trendsQuarterly Profit Report & Safe Capital Preservation Plans - newser.com
Will Celularity Inc. Equity Warrant stock maintain momentum in 20252025 Year in Review & Real-Time Stock Entry Alerts - newser.com
Quantitative breakdown of Celularity Inc. Equity Warrant recent moveQuarterly Portfolio Review & Reliable Intraday Trade Plans - newser.com
Using data models to predict Celularity Inc. Equity Warrant stock movementTrade Entry Report & AI Enhanced Trading Alerts - newser.com
Can Celularity Inc. Equity Warrant stock beat market expectations this quarterMarket Performance Summary & Verified Chart Pattern Trade Signals - newser.com
Backtesting results for Celularity Inc. trading strategiesWeekly Profit Report & Long-Term Capital Growth Ideas - newser.com
Should you wait for a breakout in Celularity Inc.Insider Selling & Technical Pattern Based Buy Signals - newser.com
What analysts say about Celularity Inc stockSector Leadership Analysis & Ride the Wave of Market-Beating Growth - earlytimes.in
What does recent volatility data suggest for Celularity Inc.Forecast Cut & High Accuracy Trade Alerts - newser.com
Is Celularity Inc. Equity Warrant stock attractive for long term wealth buildingWeekly Trend Recap & Capital Efficiency Focused Ideas - newser.com
LEVIEN VINCENT Insider Trades - Nasdaq
How to use a screener to detect Celularity Inc. Equity Warrant breakoutsJuly 2025 PostEarnings & Fast Entry Momentum Trade Alerts - newser.com
What momentum shifts mean for Celularity Inc. Equity WarrantTrade Signal Summary & Technical Pattern Based Signals - newser.com
How to interpret RSI for Celularity Inc. Equity Warrant stockRecession Risk & Trade Opportunity Analysis - newser.com
Is Celularity Inc. Equity Warrant stock entering bullish territoryMarket Volume Summary & Smart Investment Allocation Insights - newser.com
Why Celularity Inc. stock remains a top recommendationJuly 2025 Action & Fast Entry and Exit Trade Plans - newser.com
Detecting support and resistance levels for Celularity Inc. Equity Warrant2025 Growth vs Value & Risk Managed Investment Entry Signals - newser.com
Has Celularity Inc. Equity Warrant formed a bullish divergenceMarket Growth Summary & Community Consensus Picks - newser.com
Celularity Inc (CELU) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Celularity Inc 주식 (CELU) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Hariri Robert J | Chief Executive Officer |
Apr 13 '25 |
Option Exercise |
0.00 |
3,281 |
0 |
21,482 |
| Haines John R | Senior Exec Vice President |
Apr 13 '25 |
Option Exercise |
0.00 |
1,641 |
0 |
29,698 |
| Beers David C | Chief Financial Officer |
Apr 13 '25 |
Option Exercise |
0.00 |
1,025 |
0 |
18,561 |
| Brigido Stephen | Pres., Functional Regeneration |
Feb 17 '25 |
Option Exercise |
0.00 |
10,000 |
0 |
11,641 |
| Beers David C | Chief Financial Officer |
Feb 17 '25 |
Option Exercise |
0.00 |
12,500 |
0 |
21,932 |
| Haines John R | Senior Exec Vice President |
Feb 17 '25 |
Option Exercise |
0.00 |
20,000 |
0 |
35,092 |
0.41%
자본화:
|
볼륨(24시간):